兴齐眼药：11月17日召开董事会会议

Group 1 - The core point of the article is that Xingqi Eye Pharmaceutical (SZ 300573) held its 13th meeting of the 5th board of directors on November 17, 2025, to review the report on the use of previously raised funds [1] - For the first half of 2025, the company's revenue composition was 96.15% from pharmaceutical manufacturing and 3.85% from other businesses [1] - As of the report date, Xingqi Eye Pharmaceutical has a market capitalization of 17.8 billion yuan [1]